共查询到20条相似文献,搜索用时 15 毫秒
1.
Indirect ELISA with recombinant GP5 for detecting antibodies to porcine reproductive and respiratory syndrome virus 总被引:1,自引:0,他引:1
Porcine reproductive and respiratory syndrome is caused by the PRRS virus (PRRSV), which has six structural proteins (GP2,
GP3, GP4, GP5, M and N). GP5 and N protein are important targets for serological detection by enzyme-linked immunosorbent
assay (ELISA) and other methods. Toward this goal, we developed an indirect ELISA with recombinant GP5 antigens and this method
was validated by comparison to the LSI PRRSV-Ab ELISA kit. The results indicated that the optimal concentration of coated
recombinant antigen was 0.2 μg/well for a serum dilution of 1:40. The rate of agreement with the LSI PRRSV-Ab kit was 88.7%
(266/300). These results support the potential use of recombinant GP5 as an antigen for indirect ELISA to detect PRRSV antibodies
in pigs. 相似文献
2.
串联表达PRRSV M与GP5蛋白重组腺病毒的构建及其免疫特性研究 总被引:5,自引:0,他引:5
利用PCR扩增出猪繁殖与呼吸综合征病毒的M基因,按正确的读码框与GP5基因串联,成功构建穿梭载体pShuttle-CMV-M-GP5,经PCR、测序鉴定正确。PmeⅠ线性化后在BJ5183大肠杆菌内与腺病毒骨架载体pAdEasy-1同源重组,产生重组腺病毒DNA。重组腺病毒DNA经PacⅠ线性化后用脂质体转染HEK-293A细胞,在细胞内包装成完整的腺病毒,通过IFA可以检测到M与GP5串联的重组腺病毒构建成功,可以正确地表达目的蛋白。将构建好的重组腺病毒免疫小鼠,结果表明可以诱导产生较强的体液免疫应答(ELISA抗体和中和抗体)和细胞免疫应答(淋巴细胞增殖和CTL反应)。证明该重组腺病毒具有较好的免疫原性,为下一步猪体免疫试验奠定了基础。 相似文献
3.
表达猪繁殖与呼吸综合征病毒(PRRSV)GP5的重组伪狂犬病毒TK-/gG-/GP5+的构建及其生物学特性初步探讨 总被引:14,自引:2,他引:14
以伪狂犬病毒基因缺失标志疫苗株TK/gG-/LacZ 为亲本株,通过同源重组,构建了表达猪繁殖与呼吸综合征病毒(PRRSV)主要免疫原性蛋白GP5的重组伪狂犬病毒TK/gG-/GP5 .经PCR、Southern杂交、Western blot证实构建正确,并能表达GP5.同时,对重组病毒在PK-15细胞中的增殖特性进行了检测,结果与亲本株相比,增殖滴度无显著性差异.将重组病毒免疫BALB/c小鼠,2次免疫后4周,50%(3/6)小鼠产生了低水平的GP5特异性ELISA抗体,但中和抗体均小于1:4. 相似文献
4.
猪伪狂犬病毒(PRV)是一种良好的兽用活病毒疫苗载体。但以PRV基因缺失疫苗株TK-/gE-/LacZ+为载体表达PRRSV GP5的重组病毒TK-/gE-/GP5+免疫实验动物后难以激发抗PRRSV的中和抗体。为了进一步增强这种重组病毒的免疫效力,用具有更好免疫原性的修饰的ORF5基因(ORF5m)代替天然ORF5基因,构建了表达PRRSV的修饰型GP5m蛋白的重组伪狂犬病毒TK-/gE-/GP5m+。经PCR、Southern blot、Western blot 证实构建正确,并能表达具有活性的GP5m蛋白。将TK-/gE-/GP5m+与TK-/gE-/GP5+分别免疫Balb/c小鼠,结果TK-/gE-/GP5m+免疫小鼠不仅产生了较高水平的抗PRRSV的中和抗体(3/6只达到了1∶16),而且在诱导PRRSV特异性细胞免疫方面也显著优于TK-/gE-/GP5+,表明TK-/gE-/GP5m+是一种极有希望的PRRSV和PRV二价基因工程候选疫苗。 相似文献
5.
利用PCR方法分别扩增猪繁殖与呼吸综合征病毒全长GP5基因(E蛋白),EMCV的核糖体介入位点(IRES)序列及猪γ-干扰素(IFN-γ)基因全长序列,序列测定正确后用DNA重组法将三者串联后插入pAdenoVator-CM V5-IRES-GFP穿梭质粒中,形成的穿梭质粒plRES-GP5-IFN-γ用PmeⅠ线性化后,与腺病毒骨架载体pAdEasy-1共转化感受态大肠埃希氏菌BJ5183,经同源重组,构建成含有GP5基因和IFN-γ基因的重组腺病毒载体,pacⅠ酶切线性化充分暴露反向末端重复序列后,脂质体转染HEK293A细胞,借助GFP的表达可以在转染后的2~3天观察到包装病毒rAdeno-GP5-IFN-γ产生,7~10天出现病毒蚀斑。经PCR法及酶切证实各中间过程载体及最终的包装病毒中携带有目的基因,western-blot证实两基因在腺病毒中得到了表达。大肠杆菌内同源重组法能有效和较为方便的构建出含有目的基因的腺病毒载体rAdeno-GP5-IFN-γ,重组子能够在HEK293细胞中稳定扩增,病毒包装的成功为进一步研究PRRSVE蛋白的免疫效果及IFN-γ的作用奠定了基础。 相似文献
6.
应用RT-PCR方法扩增出猪繁殖与呼吸综合征病毒国内分离株S1毒株的GP5基因序列,然后通过KpnI和XhoI酶切位点把该基因克隆入经过同样双酶切的穿梭载体pShuttle-CMV中。重组穿梭载体经过酶切和PCR鉴定后进行测序,证明所克隆入的基因以正确的阅读框插入。获得的重组穿梭载体经线性化后与腺病毒骨架载体共转化大肠杆菌BJ5183菌株。纯化的重组腺病毒质粒经酶切线性化后转染293细胞获得重组腺病毒。重组腺病毒经纯化后进行RT-PCR和间接免疫荧光鉴定,证明了用PRRSVGP5蛋白基因所构建的重组腺病毒成功的表达了GP5蛋白。猪体免疫试验后收集血清进行中和实验证明所构建的重组腺病毒在猪体内能够诱导产生中和抗体,因此我们所构建的重组腺病毒可以作为PRRSV基因工程疫苗研究候选病毒株。 相似文献
7.
Farhid Hemmatzadeh Sumarningsih Sumarningsih Simson Tarigan Risa Indriani N. L. P. Indi Dharmayanti Esmaeil Ebrahimie Jagoda Igniatovic 《PloS one》2013,8(2)
Available avian influenza (AIV) serological diagnostic tests cannot distinguish vaccinated from naturally infected birds. Differentiation of vaccinated from infected animals (DIVA) is currently advocated as a means of achieving the full control of H5N1. In this study, for the first time, recombinant ectodomain of M2 protein (M2e) of avian influenza virus (H5N1 strain) was used for the DIVA serology test. M2e was cloned into pMAL-P4X vector and expressed in E. coli cells. We used Western blot to recognize the expressed M2e-MBP protein by chicken antisera produced against live H5N1 virus. Also, the specificity of M2e-MBP protein was compared to the M2e synthetic peptide via ELISA. In M2e-MBP ELISA, all sera raised against the live avian influenza viruses were positive for M2e antibodies, whereas sera from killed virus vaccination were negative. Furthermore, M2e-MBP ELISA of the field sera obtained from vaccinated and non-vaccinated chickens showed negative results, while challenged vaccinated chickens demonstrated strong positive reactions. H5N1-originated recombinant M2e protein induced broad-spectrum response and successfully reacted with antibodies against other AIV strains such as H5N2, H9N2, H7N7, and H11N6. The application of the recombinant protein instead of synthetic peptide has the advantages of continues access to an inexpensive reagent for performing a large scale screening. Moreover, recombinant proteins provide the possibility of testing the DIVA results with an additional technique such a Western blotting which is not possible in the case of synthetic proteins. All together, the results of the present investigation show that recombinant M2e-MBP can be used as a robust and inexpensive solution for DIVA test. 相似文献
8.
A E Boyer V C Tsang M L Eberhard G Zea-Flores A Hightower J B Pilcher R Zea-Flores W Zhou C B Reimer 《Journal of immunology (Baltimore, Md. : 1950)》1991,146(11):4001-4010
Ag-specific isotypic differences in immune response to Onchocerca volvulus Ag were assessed for 778 long term residents of endemic Guatemalan areas by quantitative ELISA with 5-min incubation steps and immunoblot. The study population was separated into five groups based on clinical status: N+F+, N+F-, N-F+, N-F-H+, and N-F-H-, where N = O. volvulus adults (nodule), F = microfiladermia, and H = history of O. volvulus infection. A subset of 44 individuals with high exposure to onchocerciasis from the N-F-H- group were critically evaluated and designated as "putatively immune." IgG1 reactivity to O. volvulus Ag was elevated in the majority of infected persons, but not in putatively immune individuals. Specific IgG3 levels, however, were equally elevated in all groups. The majority of N+F- persons also had elevated IgG1 levels, but they were lower than those found in F+ persons. IgG3 reactivities to a group of antigens at 20 kDa (GP20) were seen in many uninfected persons and some N+F- persons. In contrast, most F+ persons, react to this Ag with IgG1 and not IgG3. A mangabey inoculated with the infectious larval stage of O. volvulus (L3), but showed no signs of infection, began to recognize GP20 at 2 wk postinoculation. Early recognition of GP20 was possibly elicited by the larval stage. Purified nodule Ag from N+F+ individuals contained GP20, however, identical nodule Ag prepared from N+F- individuals did not. These data suggest that GP20 Ag may be common to both uterine microfilaria and the infectious larval stages. The fact that GP20 is predominantly recognized by IgG3 in putatively immune persons and some N+F- persons suggests that this increased IgG3 activity may be important in acquired immunity to onchocerciasis. 相似文献
9.
根据已发表的禽流感病毒M1基因序列设计合成PCR克隆引物,自接种H5N1亚型病毒的鸡胚组织中提取RNA,反转录后采用高可信度DNA聚合酶(PyobestTMDNA Polymerase)经PCR扩增M1基因,采用Invitrogen定向表达系统(ChampionTMpET directional TOPO expression system)进行克隆表达,纯化获得N末端携带多聚组氨酸标签的重组蛋白,分子量约29.8 kDa。采用单克隆抗体和阳性血清经ELISA、阻断ELISA、免疫印迹分析重组蛋白的免疫反应性。结果发现:重组M1蛋白能与单克隆抗体和阳性血清发生特异性结合,且此结合能被天然病毒抗原阻断。研究表明:重组蛋白M1具有良好免疫反应性。 相似文献
10.
水泡性口炎病毒核蛋白基因的表达及初步应用 总被引:3,自引:0,他引:3
将水泡性口炎病毒编码群特异性抗原的N基因片段克隆至pMD18-T克隆载体质粒中,构建N基因克隆重组质粒,进行核苷酸序列分析。然后亚克隆插入pBAD/Thio TOPO表达载体,经PCR限制性内切酶分析、测序鉴定,筛选获得N基因正向插入、有正确读码框的阳性克隆,成功构建了水泡性口炎病毒N基因重组表达载体。经L-Arabinose诱导表达,可稳定、高效地表达N蛋白抗原。SDS-PAGE、Western blotting及间接ELISA试验结果表明,表达蛋白为融合蛋白,质量约63.5 kD,其表达产量约占菌体总蛋白的16%,相当于92mg/L。融合蛋白中含有水泡性口炎病毒群特异性的核蛋白抗原,应用表达的VSV核蛋白抗原建立了酶联免疫吸附试验,通过对186份山羊、豚鼠实验动物人工感染VSV的血清样品和参考血清样品的检测,并与微量血清中和试验进行了比较,结果表明:以表达的VSV核蛋白为包被抗原的酶联免疫吸附试验是一种特异性强、敏感性高、快速、简单、安全的检测方法,抗原制备成本低。 相似文献
11.
牛疱疹病毒Ⅰ型VP22和猪繁殖与呼吸综合征病毒GP5融合基因DNA疫苗的免疫效应 总被引:2,自引:0,他引:2
为了提高表达GP5的猪繁殖与呼吸综合征病毒(PRRSV)DNA疫苗的免疫效应,将具有蛋白转导功能的牛疱疹病毒1型(BHV-1)VP22基因插入到经过修饰具有更好免疫原性的PRRSV修饰型ORF5基因(ORF5M)上游,构建VP22和ORF5M融合表达的真核表达质粒pCI-VP22-ORF5M。经间接免疫荧光试验(IFA)和Westernblot检测证实体外表达后,免疫BALB/c小鼠,检测小鼠免疫后的GP5特异性ELISA抗体、抗PRRSV中和抗体和脾淋巴细胞增殖反应,并与非融合的真核表达质粒pCI-ORF5M进行比较。结果显示,融合表达VP22-GP5的DNA疫苗 pCI-VP22ORF5M诱导的体液免疫和细胞免疫反应均明显高于非融合表达的DNA疫苗pCI-ORF5M,表明蛋白转导相关蛋白BHV-1 VP22能显著增强表达GP5的PRRSV DNA 疫苗的免疫效应,有效发挥了基因免疫佐剂效应;这为研制PRRSV高效DNA疫苗奠定了基础,同时也为其它疾病的高效新型疫苗研究提供了思路。 相似文献
12.
Previously, we have determined the nucleotide and amino acid sequences of the variable domains of three mouse monoclonal antibodies specific to the individual epitopes of the Ebola virus glycoprotein: GPE118 (IgG), GPE325 (IgM) and GPE534 (IgG) [1]. In the present paper, chimeric Fab fragments of Fab118, Fab325, and Fab534 antibodies were obtained based on the variable domains of murine antibodies by attaching CH1 and CL constant regions of human kappa-IgG1 to them. The recombinant chimeric Fab fragments were synthesized in the heterologous expression system Escherichia coli, isolated and purified using metal chelate affinity chromatography. The immunochemical properties of the obtained Fab fragments were studied by immunoblotting techniques as well as indirect and competitive ELISA using recombinant Ebola virus proteins: EBOV rGPdTM (recombinant glycoprotein of Ebola hemorrhagic fever virus without the transmembrane domain), NP (nucleoprotein) and VP40 (structural protein). The identity of recombinant chimeric Fab fragments, as well as their specificity to the recombinant glycoprotein of Ebola hemorrhagic fever virus (EBOV GP) was proved. The results of indirect ELISA evidence the absence of immunological cross-reactivity to NP and VP40 proteins of Ebola virus. The dissociation constants of the antigen-antibody complex K d equal to 5.0, 1.0 and 1.0 nM for Fab118, Fab325 and Fab534, respectively, were determined; they indicate high affinity of the obtained experimental samples to EBOV GP. The epitope specificity of Fab fragments was studied using a panel of commercial neutralizing antibodies. It was found that all studied antibodies to EBOV GP are targeted to different epitopes, while the epitopes of the recombinant chimeric Fab fragments and original murine monoclonal antibodies (mAbs) coincide. All the obtained and studied mAbs to EBOV GP are specific to epitopes that coincide or overlap the epitopes of three commercial neutralizing mAbs to Ebola virus: epitopes Fab118 and Fab325 overlap the epitope of the known commercial mAb h13F6; Fab325 epitope also overlaps mAb c6D8 epitope; Fab534 epitope is located near mAb KZ52 conformational epitope, in the formation of which amino acid residues of GP1 and GP2 domains of EBOV GP are involved. 相似文献
13.
Pseudorabies virus (PRV),an alpha-herpesvirus,has been developed as a live viral vector for animal vaccines.However,the PRV recombinant virus TK-/gE-/GP5+expressing GP5 of porcine reproductive and respiratory syndrome virus (PRRSV),based on the PRV genetically depleted vaccine strain TK-/gE-/LacZ+,scarcely stimulated the vaccinated animals to produce neutralizing antibodies against PRRSV.To develop a booster-specific immune response of such PRV recombinants,the ORF5m gene (the modified ORF5 gene having better immune responses)was substituted for the ORF5 gene and introduced into PRV TK-/gE-/LacZ+,resulting in a PRV recombinant named TK-/gE-/GPSm+,which expressed the modified GPSm protein.The recombinant virus was confirmed using PCR,Southern blotting and Western blotting.TK-/gE-/GPSm+and TK-/gE-/GP5+expressing the authentic GP5 protein were inoculated into Balb/c mice to evaluate their immune responses.The results indicated that the protecting neutralization antibodies (the 3/6 vaccinated mice obtained 1:16)and cell immune responses induced by TK-/gE-/GPSm+against PRRSV were higher than that induced by TK-/gE-/GP5+.Thus,the development of the new PRV recombinant expressing the modified GP5m protein as a candidate vaccine established the basis for the study of bivalent genetic engineering vaccines against PRRSV and PRV. 相似文献
14.
目的:探讨泛素基因对GP5基因免疫的影响。泛素-蛋白酶体途径是一种高效蛋白降解途径,主要负责真核细胞内蛋白选择性降解。方法:本研究将ORF5DNA片段克隆到含泛素(Ub)基因的表达载体pCMV-Ub和pCMV载体,构建成重组质粒pCMV—Ub-GP5和pCMV-GP5。两种质粒DNA肌肉注射免疫BALb/c小鼠后,分别检测体液免疫反应和细胞免疫反应,比较GP5单基因和Ub—GP5融合基因DNA免疫所诱生免疫应答的强度。结果:二者均可诱生PRRSVELISA抗体和中和抗体,其抗体水平无明显差别,但Ub-GP5融合基因诱生的淋巴细胞反应和CTL反应明显高于GP5基因。结论:泛素基因可以促进GP5诱生细胞免疫反应。 相似文献
15.
为了构建结核分枝杆菌(MTb)esat6基因表达载体并在戈登链球菌GP251中进行分泌表达, 以结核杆菌H37Rv基因组DNA为模板扩增esat6基因, 将esat6基因TA克隆到pMD18-T, 构建pMD18-esat6重组载体。酶切消化pMD18-esat6, 将esat6基因亚克隆到质粒PSMB104, 生成PSMB104-esat6重组载体, 用于转化感受态戈登链球菌表达菌株GP251。用Tricine-SDS-PAGE和Western印迹检测esat6蛋白的表达, 并用ELISA技术检测该蛋白 相似文献
16.
共表达猪呼吸与繁殖障碍综合征病毒NJ-a株ORF4、ORF5与ORF6基因重组改良型痘苗病毒安卡拉株的构建 总被引:4,自引:0,他引:4
为探讨共表达猪繁殖与呼吸综合征病毒(Porcinerep roductive and respiratory syndrome Virus,PRRSV)保护性抗原基因的重组改良型痘苗病毒安卡拉株(Modified Vaccinia Virus Ankala,MVA)的免疫效力,将PRRSVNJ-a株ORF4、ORF5和ORF6基因插入转移载体pⅡLR中,获得了三基因共表达的转移载体pⅡLR-ORF5/ORF6/ORF4,通过同源重组的方法获得重组病毒rMVA-GP5/M/GP4。以lacZ为报告基因进行噬斑筛选和重组病毒纯化后,PCR方法证明ORF4、ORF5和ORF6成功的插入MVA基因组中;经Western blot检测与间接免疫荧光试验证实,重组病毒感染细胞能正确表达PRRSVGP4、GP5与M蛋白。用rMVA-GP5/M/GP4免疫6周龄Babl/C小鼠,首免后3周可检测到特异性PRRSV中和抗体,8周后中和抗体效价可达25,并能继续维持4周;淋巴细胞增殖试验结果表明,重组病毒免疫小鼠产生强烈的特异性细胞增殖反应。上述研究结果表明rMVA-GP5/M/GP4具有良好的免疫原性,可作为预防PRRS的候选疫苗进一步研究。 相似文献
17.
人重组t-PA突变体与β2糖蛋白Ⅰ的相互作用 总被引:1,自引:0,他引:1
利用重组DNA技术和原核表达,得到了人体组织型纤溶酶原激活剂t-PA 的缺失型突变体r-PA和Kringle2功能区,并在变性条件下通过金属螯合层析纯化得到纯度较高的r-PA和Kringle2重组蛋白.用纤维蛋白活性平板检测到复性的r-PA和Kringle2都具有体外纤溶活性,并且β 2糖蛋白Ⅰ (β2-glycoprotein Ⅰ, β2GPⅠ)对r-PA的体外纤溶活性有显著的促进作用:在β2GPⅠ浓度为1 μmol/L和4 μmol/L时,r-PA的纤溶活性分别提高1.8和2.1倍.ELISA方法检测发现, β2GPⅠ与r-PA,Kringle2均有特异性结合,并且随着β2GPⅠ浓度的增加,它与包被在酶标板上的重组蛋白r-PA和Kringle2的结合都有趋于饱和的趋势,但其饱和浓度却均远高于β2GPⅠ与t-PA结合的饱和浓度. 相似文献
18.
重组乳酸乳球菌表达禽流感病毒HA1基因载体的构建及在禽流感病毒防治领域的应用 总被引:1,自引:0,他引:1
目的构建以重组乳酸乳球菌为基础的黏膜输送载体。方法以高致病性禽流感病毒H5N1的HA1基因作为研究对象,利用nisin诱导表达控制系统,构建分泌型与非分泌型重组乳酸乳球菌表达载体,经口服灌胃途径免疫BALB/c小鼠,通过ELISA检测小鼠血清IgG和粪便IgA,最后,对免疫后的小鼠进行H5N1病毒攻击实验,进而比较分泌型与非分泌型重组乳酸乳球菌表达载体的免疫效率。结果分泌型重组乳酸乳球菌免疫小鼠后产生的抗体水平(IgG和IgA)高于非分泌型重组乳酸乳球菌,经过同型H5N1病毒攻击后,分泌型重组乳酸乳球菌免疫的小鼠的存活率为80%,而非分泌型重组乳酸乳球菌免疫的小鼠的存活率为60%。结论本研究为防治高致病性禽流感病毒提供可行的思路与方法。 相似文献
19.
应用斑点金免疫渗滤试验(dotimmunogoldfiltrationassay,DIGFA)建立了一种同步快速检测四种抗HIV-1/2IgG抗体的HIV诊断试纸。通过基因工程技术在大肠杆菌中表达了5种HIV抗原蛋白片段(P24,GP41,GP36,GP120V3,GP120C)。这5种抗原蛋白首先被固定在硝酸纤维素膜上,然后滴加待测血清,其中的病毒抗体通过免疫反应与抗原结合,再加胶体金标记的葡萄球菌蛋白A(SPA),待其渗过膜片后,洗涤,即可形成肉眼可见的红色斑点。用已确证的21份HIV阳性血清(其中包括1份HIV-1标准阳性血清和1份HIV-2标准阳性血清)和30份阴性血清进行了试验,结果表明该快速检测方法与ELISA方法无显著差异。该检测方法不需任何仪器,仅凭肉眼即可判定结果,整个检测过程不超过5分钟。与传统的的ELISA法相比,具有方便快速,成本低廉,应用范围广等优点。同时,此HIV快速诊断试纸可以同步检测并区分针对HIV-1和HIV-2感染的不同检测标志物(抗P24、GP41、GP120和GP36抗体),这对提高快速检测的灵敏度和准确性,以及对判断HIV感染者是否临近或已进入AIDS期有着较高的应用价值。 相似文献
20.
The epitope study on the SARS-CoV nucleocapsid protein 总被引:6,自引:0,他引:6
Li S Lin L Wang H Yin J Ren Y Zhao Z Wen J Zhou C Zhang X Li X Wang J Zhou Z Liu J Shao J Lei T Fang J Xu N Liu S 《基因组蛋白质组与生物信息学报(英文版)》2003,1(3):198-206
The nucleocapsid protein (N protein) has been found to be an antigenic protein in a number of coronaviruses. Whether the N protein in severe acute respiratory syndrome-associated coronavirus (SARS-CoV) is antigenic remains to be elucidated. Using Western blot and Enzyme-linked Immunosorbent Assay (ELISA), the recombinant N proteins and the synthesized peptides derived from the N protein were screened in sera from SARS patients. All patient sera in this study displayed strong positive immunoreactivities against the recombinant N proteins, whereas normal sera gave negative immunoresponses to these proteins, indicating that the N protein of SARS-CoV is an antigenic protein. Furthermore, the epitope sites in the N protein were determined by competition experiments, in which the recombinant proteins or the synthesized peptides competed against the SARS-CoV proteins to bind to the antibodies raised in SARS sera. One epitope site located at the C-terminus was confirmed as the most antigenic region in this prot 相似文献